Reports - Artificial Intelligence (ai) In Drug Discovery Market
HealthcareArtificial Intelligence (ai) In Drug Discovery Market
Artificial Intelligence (ai) In Drug Discovery Market Size and Share Analysis for 2035 by Application (Drug Optimization & Repurposing, Preclinical Testing, Other Applications) by Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Other Areas) by Component (Software, Hardware, Services) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Global Artificial Intelligence (ai) In Drug Discovery Market, 2021 - 2035 (USD Million)
3. Global Artificial Intelligence (ai) In Drug Discovery Market - by Application
3.1. By Drug Optimization & Repurposing
3.2. By Preclinical Testing
3.3. By Other Applications
4. Global Artificial Intelligence (ai) In Drug Discovery Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Diseases
4.4. By Metabolic Diseases
4.5. By Infectious Diseases
4.6. By Other Areas
5. Global Artificial Intelligence (ai) In Drug Discovery Market - by Component
5.1. By Software
5.2. By Hardware
5.3. By Services
6. Global Artificial Intelligence (ai) In Drug Discovery Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. North America Artificial Intelligence (ai) In Drug Discovery Market, 2021 - 2035 (USD Million)
3. North America Artificial Intelligence (ai) In Drug Discovery Market - by Application
3.1. By Drug Optimization & Repurposing
3.2. By Preclinical Testing
3.3. By Other Applications
4. North America Artificial Intelligence (ai) In Drug Discovery Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Diseases
4.4. By Metabolic Diseases
4.5. By Infectious Diseases
4.6. By Other Areas
5. North America Artificial Intelligence (ai) In Drug Discovery Market - by Component
5.1. By Software
5.2. By Hardware
5.3. By Services
Chapter 5 Europe Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Europe Artificial Intelligence (ai) In Drug Discovery Market, 2021 - 2035 (USD Million)
3. Europe Artificial Intelligence (ai) In Drug Discovery Market - by Application
3.1. By Drug Optimization & Repurposing
3.2. By Preclinical Testing
3.3. By Other Applications
4. Europe Artificial Intelligence (ai) In Drug Discovery Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Diseases
4.4. By Metabolic Diseases
4.5. By Infectious Diseases
4.6. By Other Areas
5. Europe Artificial Intelligence (ai) In Drug Discovery Market - by Component
5.1. By Software
5.2. By Hardware
5.3. By Services
Chapter 6 Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market, 2021 - 2035 (USD Million)
3. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market - by Application
3.1. By Drug Optimization & Repurposing
3.2. By Preclinical Testing
3.3. By Other Applications
4. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Diseases
4.4. By Metabolic Diseases
4.5. By Infectious Diseases
4.6. By Other Areas
5. Asia Pacific Artificial Intelligence (ai) In Drug Discovery Market - by Component
5.1. By Software
5.2. By Hardware
5.3. By Services
Chapter 7 Latin America Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Latin America Artificial Intelligence (ai) In Drug Discovery Market, 2021 - 2035 (USD Million)
3. Latin America Artificial Intelligence (ai) In Drug Discovery Market - by Application
3.1. By Drug Optimization & Repurposing
3.2. By Preclinical Testing
3.3. By Other Applications
4. Latin America Artificial Intelligence (ai) In Drug Discovery Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Diseases
4.4. By Metabolic Diseases
4.5. By Infectious Diseases
4.6. By Other Areas
5. Latin America Artificial Intelligence (ai) In Drug Discovery Market - by Component
5.1. By Software
5.2. By Hardware
5.3. By Services
Chapter 8 Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market - Segment Analysis
1. Overview
2. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market - by Application
3.1. By Drug Optimization & Repurposing
3.2. By Preclinical Testing
3.3. By Other Applications
4. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market - by Therapeutic Area
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Diseases
4.4. By Metabolic Diseases
4.5. By Infectious Diseases
4.6. By Other Areas
5. Middle East & Africa Artificial Intelligence (ai) In Drug Discovery Market - by Component
5.1. By Software
5.2. By Hardware
5.3. By Services
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. IBM Watson (U.S.)
2. Exscientia (UK)
3. GNS Healthcare (U.S.)
4. Alphabet (U.S.)
5. Benevolent AI (UK)
6. BioSymetrics Inc. (Canada)
7. Euretos (Netherlands)
8. Berg Health (U.S.)
9. Atomwise (U.S.)
10. Insitro (U.S.)
11. Cyclica Inc. (Canada)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By